Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study
- PMID: 24151437
- PMCID: PMC3804791
- DOI: 10.7150/ijms.6415
Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study
Abstract
Objective: The natural history of acute-on-chronic hepatitis B liver failure (ACHBLF) is complex and highly variable. However, the global clinical characteristics of this entity remain ill-defined. We aimed to investigate the dynamic patterns of the natural progression as well as their impact on the outcomes of ACHBLF.
Methods: The clinical features and disease states were retrospectively investigated in 54 patients with ACHBLF at the China South Hepatology Center. The clinical and laboratory profiles including hepatic encephalopathy (HE), hepatorenal syndrome (HRS), and spontaneous bacterial peritonitis (SBP) were evaluated. The disease state estimated by the model for end-stage liver disease (MELD) score and the dynamic patterns during the clinical course of ACHBLF were extrapolated.
Results: Twenty-two patients died during the 3-month follow-up period (40.74%). The patients were predominantly male (88.89%). Baseline characteristics showed that there were significant differences in only hepatitis B virus (HBV) DNA levels and platelet count between the deceased and surviving patients (P=0.014 and P=0.012, respectively). Other baseline characteristics were similar in both groups. The dynamic state of the MELD score gradually increased from an initial hepatic flare until week 4 of ACHBLF progression. There were notable changes of the dynamic state of the MELD score at two time points (week 2 and week 4) during ACHBLF progression. The MELD scores were significantly greater in the death group (24.80 ± 2.99) than in the survival group (19.49±1.96, P<0.05) during the clinical course of ACHBLF; the MELD scores of the survival group began to decrease from week 4, while they continued to rise and eventually decreased as more patients died. The gradients of the ascent and descent stages could predict exactly the severity and prognosis of ACHBLF.
Conclusions: The natural progression of ACHBLF could be divided approximately into four stages including ascent, plateau, descent, and convalescence stages according to different trends of liver failure progression, respectively. Thus, the special patterns of the natural progression of ACHBLF may be regarded as a significant predictor of the 3-month mortality of ACHBLF.
Keywords: Acute-on-chronic hepatitis B liver failure; Clinical features; Dynamic patterns; Prognosis; and MELD score..
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures



Similar articles
-
Hypermethylation of thymosin β4 predicts a poor prognosis for patients with acute-on-chronic hepatitis B liver failure.Hepatobiliary Pancreat Dis Int. 2023 Aug;22(4):373-382. doi: 10.1016/j.hbpd.2022.08.005. Epub 2022 Aug 19. Hepatobiliary Pancreat Dis Int. 2023. PMID: 36041971
-
Hypermethylation of the galectin-3 promoter is associated with poor prognosis of acute-on-chronic hepatitis B liver failure.Dig Liver Dis. 2017 Jun;49(6):664-671. doi: 10.1016/j.dld.2017.01.158. Epub 2017 Jan 22. Dig Liver Dis. 2017. PMID: 28185839
-
Methylation status of the estrogen receptor 1 promoter predicts poor prognosis of acute-on-chronic hepatitis B liver failure.Rev Esp Enferm Dig. 2017 Dec;109(12):818-827. doi: 10.17235/reed.2017.4426/2016. Rev Esp Enferm Dig. 2017. PMID: 29082740
-
Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure.World J Gastroenterol. 2017 Oct 28;23(40):7303-7309. doi: 10.3748/wjg.v23.i40.7303. World J Gastroenterol. 2017. PMID: 29142477 Free PMC article.
-
Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.Dig Dis Sci. 2011 Apr;56(4):977-87. doi: 10.1007/s10620-010-1390-3. Epub 2010 Sep 16. Dig Dis Sci. 2011. PMID: 20844956 Review.
Cited by
-
Liver transplantation in acute-on-chronic liver failure: lessons learnt from acute liver failure setting.Hepatol Int. 2015 Oct;9(4):508-13. doi: 10.1007/s12072-014-9603-z. Epub 2015 Jan 8. Hepatol Int. 2015. PMID: 25788191 Review.
-
A Prospective Multicenter Study of the Chinese Scoring System for Hepatitis B Liver Failure.Front Med (Lausanne). 2021 Nov 2;8:751807. doi: 10.3389/fmed.2021.751807. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34796187 Free PMC article.
-
Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.Hepat Mon. 2014 Jul 14;14(7):e19370. doi: 10.5812/hepatmon.19370. eCollection 2014 Jul. Hepat Mon. 2014. PMID: 25147572 Free PMC article.
-
Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.World J Gastroenterol. 2014 Nov 21;20(43):16037-52. doi: 10.3748/wjg.v20.i43.16037. World J Gastroenterol. 2014. PMID: 25473156 Free PMC article.
-
The Management of Glucocorticoid Therapy in Liver Failure.Front Immunol. 2019 Oct 23;10:2490. doi: 10.3389/fimmu.2019.02490. eCollection 2019. Front Immunol. 2019. PMID: 31749799 Free PMC article. Review.
References
-
- Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER. et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6(12):1315–1341. - PubMed
-
- McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S45–55. - PubMed
-
- Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011;53(3):774–780. - PubMed
-
- Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL. et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470. - PubMed
-
- Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P. et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49(2):646–657. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources